Why are men more likely to develop multiple myeloma than women? Dr. Kamal Kant Kohli19 Jan 2026 9:15 PM ISTRates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A...
Color Blindness Linked to Increased Bladder Cancer Mortality Risk: Study Medha Baranwal18 Jan 2026 8:00 PM ISTUSA: A retrospective cohort study found that people with color vision deficiency may have a higher risk of mortality from bladder cancer, possibly due...
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics: Study Dr. Kamal Kant Kohli17 Jan 2026 9:00 AM ISTA novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously...
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy: Study Dr. Kamal Kant Kohli15 Jan 2026 9:00 PM ISTAccording to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel...
New risk score helps predict pancreatic cancer recurrence, finds study Dr. Kamal Kant Kohli14 Jan 2026 8:00 PM ISTCedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic...
Thyroid gland new possible target for prostate cancer treatment: Study Dr. Kamal Kant Kohli13 Jan 2026 8:30 PM ISTA hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international...
HCC Treatment Shifts Toward Immunotherapy, but Survival Gains Remain Limited: JAMA Study Shows Medha Baranwal12 Jan 2026 8:15 PM ISTUSA: A large real-world analysis published in JAMA Network Open offers new insights into how systemic treatment strategies for hepatocellular...
GLP-1 Use Linked to Improved Survival and Fewer Complications in patients with Diabetes and Cancer: Study Dr. Shravani Dali12 Jan 2026 11:00 AM ISTResearchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a lower risk of death compared...
Hot flush treatment has anti-breast cancer activity, study finds Dr. Kamal Kant Kohli9 Jan 2026 8:15 PM ISTA drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast...
Oncology Events 2026: International Conferences, Dates & Locations Dr. Bhumika Maikhuri9 Jan 2026 10:30 AM ISTCancer represents a major public health and economic challenge in the 21st century, accounting for one in six deaths and one in four deaths from...
Breast MRI Can Be Safely Omitted in Selected Patients With Early-Stage HR-Negative Breast Cancer: Study Dr. Kamal Kant Kohli8 Jan 2026 8:15 PM ISTPatients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they...
Abemaciclib's New Overall Survival Data in Early Breast Cancer: Findings from MonarchE trial Dr. Bhumika Maikhuri8 Jan 2026 12:00 PM ISTIn this short video, Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital and Institute of Cancer Research, London, ...
